scholarly journals Behavioral Patterns and Associations with Glucose Control During 12-Week Randomized Free-Living Clinical Trial of Day and Night Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes

2017 ◽  
Vol 19 (7) ◽  
pp. 433-437 ◽  
Author(s):  
Ali Emami ◽  
Malgorzata E. Willinska ◽  
Hood Thabit ◽  
Lalantha Leelarathna ◽  
Sara Hartnell ◽  
...  
Diabetes Care ◽  
2016 ◽  
Vol 39 (7) ◽  
pp. 1168-1174 ◽  
Author(s):  
Martin Tauschmann ◽  
Janet M. Allen ◽  
Malgorzata E. Wilinska ◽  
Hood Thabit ◽  
Zoë Stewart ◽  
...  

Diabetes Care ◽  
2014 ◽  
Vol 37 (5) ◽  
pp. 1204-1211 ◽  
Author(s):  
Roman Hovorka ◽  
Daniela Elleri ◽  
Hood Thabit ◽  
Janet M. Allen ◽  
Lalantha Leelarathna ◽  
...  

2018 ◽  
Vol 12 (6) ◽  
pp. 1125-1131 ◽  
Author(s):  
Conor Farrington ◽  
Zoe Stewart ◽  
Roman Hovorka ◽  
Helen Murphy

Aims: Closed-loop insulin delivery has the potential to improve day-to-day glucose control in type 1 diabetes pregnancy. However, the psychosocial impact of day-and-night usage of automated closed-loop systems during pregnancy is unknown. Our aim was to explore women’s experiences and relationships between technology experience and levels of trust in closed-loop therapy. Methods: We recruited 16 pregnant women with type 1 diabetes to a randomized crossover trial of sensor-augmented pump therapy compared to automated closed-loop therapy. We conducted semistructured qualitative interviews at baseline and follow-up. Findings from follow-up interviews are reported here. Results: Women described benefits and burdens of closed-loop systems during pregnancy. Feelings of improved glucose control, excitement and peace of mind were counterbalanced by concerns about technical glitches, CGM inaccuracy, and the burden of maintenance requirements. Women expressed varied but mostly high levels of trust in closed-loop therapy. Conclusions: Women displayed complex psychosocial responses to day-and-night closed-loop therapy in pregnancy. Clinicians should consider closed-loop therapy not just in terms of its potential impact on biomedical outcomes but also in terms of its impact on users’ lives.


2015 ◽  
Vol 3 (12) ◽  
pp. 939-947 ◽  
Author(s):  
Jort Kropff ◽  
Simone Del Favero ◽  
Jerome Place ◽  
Chiara Toffanin ◽  
Roberto Visentin ◽  
...  

Diabetes Care ◽  
2016 ◽  
Vol 39 (11) ◽  
pp. 2019-2025 ◽  
Author(s):  
Martin Tauschmann ◽  
Janet M. Allen ◽  
Malgorzata E. Wilinska ◽  
Hood Thabit ◽  
Carlo L. Acerini ◽  
...  

2018 ◽  
Vol 19 (8) ◽  
pp. 1451-1458 ◽  
Author(s):  
Paulina Ortiz‐Rubio ◽  
Adeolu Oladunjoye ◽  
Michael S. D. Agus ◽  
Garry M. Steil

The Lancet ◽  
2015 ◽  
Vol 385 ◽  
pp. S96 ◽  
Author(s):  
Hood Thabit ◽  
Daniela Elleri ◽  
Lalantha Leelarathna ◽  
Janet Allen ◽  
Alexandra Lubina-Solomon ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document